CSG’s €100M+ NATO Fuse Order and 83% Profit Surge Are No Match for a Bitter Shareholder Feud
10.06.2026 - 15:05:12 | boerse-global.de
A defense contractor boasting an 83% leap in net profit, a €17 billion order backlog, and unanimous buy ratings from every analyst covering the stock — yet its shares have shed more than 60% from January’s peak. The culprit is not weak demand or operational missteps, but a governance quarrel that has frozen investor sentiment.
The bone of contention centers on Petr KratochvĂl, a minority shareholder who holds roughly 10% of CSG Land Systems CZ and about 9% of the MSM Group. He is demanding €1.4 billion for his stakes — a valuation CSG rejects, offering less than one-tenth of that figure. The gulf, equivalent to 31 billion Czech koruna, has brought negotiations to a standstill and drawn in courts in both the Czech Republic and Slovakia. KratochvĂl was removed as chairman in March over an alleged conflict of interest and has since challenged not only the valuation of his holdings but also internal share transfers. For investors, the legal fog has become a layer of risk that stellar operating metrics cannot dispel.
Yet even as the courtroom drama intensifies, CSG continues to land major contracts. The company announced that two unnamed European NATO members have placed an order for mechanical and electronic fuses for large-caliber ammunition, valued in the high double-digit millions of euros. Deliveries are set to begin later this year. The electronic fuses will be manufactured by Fuchs Electronics Europe, a newly established joint venture between CSG and South African partner Reunert, with production facilities in Slovakia. The deal underscores CSG’s push to cement its foothold in technologically sophisticated artillery components.
Should investors sell immediately? Or is it worth buying CSG?
Operationally, the numbers are hard to fault. First-quarter revenue hit €1.544 billion, while operating EBIT rose 8.7% to €372 million. Net profit surged 83% year-on-year. The operating margin landed within the targeted 24-25% corridor. Management confirmed its full-year revenue forecast of €7.4 billion to €7.6 billion. The order book swelled 15.1% to €17 billion, with an additional €27 billion in pipeline negotiations.
That disconnect is starkly illustrated by the analyst community. All ten brokers covering CSG rate the stock a buy, with a median price target of €32.05 — more than double the current share price of around €14.37. Berenberg trimmed its estimates after mixed segment results but held firm on its buy recommendation. Despite this wall of support, the market remains unconvinced.
CSG has also been quietly tightening its grip on the ammunition supply chain. In early June, it emerged that the group had accumulated nearly 10% of voting rights in Alzchem Group through its subsidiary STALUNA TRADE, plus financial instruments representing another roughly 10%. Alzchem produces nitroguanidine, a key ingredient in propellants and munitions. And on June 1, a licensing partnership with Ukrainian Armor kicked off, putting NATO-standard artillery shells into production in Ukraine. Initial plans call for 100,000 rounds of 155mm and 50,000 rounds of 105mm annually, with CSG targeting a total heavy-caliber production run of 850,000 shells by end-2026, up from 550,000 forecast for 2025.
Technically, the stock looks deeply oversold. The relative strength index stands at 28.9, and the price is more than 24% below its 50-day moving average. That alone would normally trigger bargain-hunting, but the legal overhang has rendered such signals ineffective. First-instance rulings from courts in Prague or Bratislava could shift the picture abruptly — in either direction. The next scheduled catalyst is the half-year report on August 7, with the quiet period beginning July 8. Until then, investors remain caught between world-class operational performance and a governance risk that refuses to fade.
Ad
CSG Stock: New Analysis - 10 June
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
